Cell Genesys

                   
genengnews.com: Genetic Engineering genengnews.com

Final Results From Phase 2 Clinical Trial of GVAX Immunotherapy for Prostate Cancer Published in...

genengnews.com     yesterday   100 related          

News source: Business Wire Cell Genesys, Inc. announced today the publication of final data from the second of two Phase 2 clinical trials (G-0010) of GVAX immunotherapy for prostate cancer in the online issue of Cancer, a...                

comments (1)

                   

InPlay: General Electric and Mubadala launch multi-billion dollar global business partnership...

yahoo.com     yesterday   26 related          

8:35AM New Oriental expects FY09 revenues will increase at least 20% 3.91 : According to the Co, it expects another year of record sales and profits, with full year Fiscal 2009 revenues increasing at least 20% as compared with...                

comments

                   

Cell Genesys shares jump on as 1Q results top Wall Street (AP)

yahoo.com     Jul 12, 2008          

Friday May 2, 6:35 pm ET Cell Genesys shares rise after company posts narrower 1st-qtr loss than analysts project NEW YORK (AP) -- Shares of Cell Genesys Inc. jumped Friday after the biotech company reported a narrower...                

comments

BeaconEquity.com Issues TraderNotes on Active Stocks: SWHC, ARNA, BORL, QTWW, CSGH, FEED, BVN, CEGE

earthtimes.org     Jun 27, 2008   9 related          

DALLAS, June 27 TX-BeaconEquity-notes DALLAS, June 27 -- BeaconEquity.com announces the availability of TraderNotes on stocks that are making news today. Investors can view all of the daily trading notes for free by visiting:...                

comments

                   

Immutep Reports that LAG-3 Enhances Activity of a Cellular Cancer Immunotherapy in Preclinical...

drugs.com     Jun 27, 2008   1 related          

Research paper describes increase in potency of a GM-CSF-secreting tumor cell immunotherapy by a LAG-3 fusion protein immunopotentiator ORSAY, France, June 25th, 2008 - Immutep S.A., a biopharmaceutical company specialized in...                

comments

                   

DotW: The Heat Is On

invivoblog.blogspot.com     Jun 13, 2008   387 related          

The temperature has been hot--and so has the deal-making. And that was before the week's biggest deals: the Ranbaxy/ Daiichi Sankyo and Invitrogen/ Applied Biosystems tie-ups (see below).It's an odd week for heavy deal flow,...                

comments

3 Top PowerRatings Pullbacks Under $10: NLS, RTK, CEGE (TradingMarkets.com)

yahoo.com     Jun 11, 2008   12 related          

With the Dow showing a lot of strength during Thursday morning trading, many stock that were previously pulling back are now finding buyers. Here are 3 stocks with high Short Term PowerRatings that may soon be following suit.                

comments

Cell Genesys to Present at the Needham & Company Seventh Annual Biotechnology and Medical...

finanznachrichten.de     Jun 4, 2008          

Cell Genesys, Inc. (Nasdaq:CEGE) today announced that Sharon E. Tetlow, senior vice president and chief financial officer of Cell Genesys, will present a company update on Wednesday, June 11, 2008 at 10:30 a.m. ET at the...                

comments

High PowerRating, Low Price: 5 Stocks for Traders (TradingMarkets.com)

yahoo.com     May 30, 2008   7 related          

Friday May 30, 11:59 am ET By David Penn With stocks starting off Friday mildly higher, a number of top quality pullbacks that were setting up on Thursday remain attractive opportunities for traders here on Friday. Today we are...                

comments

                   

New Report Analyzes the Current and Future Potential of Cancer Vaccines

redorbit.com     May 29, 2008          

Posted on: Thursday, 29 May 2008, 12:00 CDT Research and Markets (http://www.researchandmarkets.com/reports/c93083) has announced the addition of Cancer Vaccines: Aim and Shoot to their offering. This report aims to analyze the current and future potential of cancer vaccines by examining key...                

comments

1 2 3 4 5 next »